Prof Adam Waldman

MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

The overall theme of my research is development and validation of quantitative and molecular imaging biomarkers which reflect key features of genetics and metabolism in human glioma, for clinical stratification, therapeutic planning and drug development:

Experimental phase MRI and PET imaging studies of intermediary metabolism, validated against tissue metabolic markers from defined tumour regions; for more reliable tumour characterisation, and identification of potential therapeutic targets.

Translational multi-centre platform studies of early therapeutic response in GBM using quantitative diffusion imaging for improved endpoints in clinical trials and clinical decision-making.

Quantitative MRI for treatment stratification and planning in adult supratentorial low grade glioma.

Development of PET-MRI methodology and co-analysis for improved glioma characterization.

Integration of quantitative MRI and PET into surgical neuro-navigation systems, for improved targeting for biopsy and surgical resection.

dont miss

Biomarkers in Adult Glioma

EVEN MORE SEMINARS

  • Mani Naghibi: Speaking at the Oncology Convention

    Mani Naghibi
    St. Mark's Hospital

    Using nutrition therapies to positively effect cancer treatment outcomes

  • Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd: Speaking at the Oncology Convention

    Imran Liaquat MBChB BSc MedSci MRCS FRCS MEd
    NHS Lothian, Scotland

    Optimising Surgical Resection in Low Grade Glioma Patients

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Dr Ioanna Nixon: Speaking at the Oncology Convention

    Dr Ioanna Nixon
    Beatson West of Scotland Cancer center, NHS Greater Glasgow and Clyde

    When the oncologist meets the patient: value of compassion. How well are we doing?

  • Chris Curtis: Speaking at the Oncology Convention

    Chris Curtis
    The Swallows Head & Neck Cancer Charity

    A patient’s journey ‘Cancer to the palace in 6yrs’